Последние новости

Реклама

В.В СКЛЯРЕВИЧ. Антибактериальные лекарственые средства. Методы стандартизации препаратов. Раздел 2

В.В СКЛЯРЕВИЧ. Антибактериальные лекарственые средства. Методы стандартизации препаратов. Страница 133

22. Aubier M.y Verster R., Regamey C. et al. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group // Clin. Infect. Dis. - 1998. - Vol. 26 (6). - P. 1312- 1320/45.

23. Roson B., Carratala J., Tubau F et al. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone // Microb. Drug. Resist. — 2001. — Vol. 7 (1). — P. 85-96.

24. Fogarty C. M., Cyganowski M., Palo W. A. et al A comparison of cefdi- toren pivoxil and amoxicillin/clavulanate in the treatment of communi- ty-acquired pneumonia: a multicenter, prospective, randomized, inves- tigator-blinded, parallel-group study // Clin. Ther. — 2002. — Vol. 24 (11).- P. 1854-1870.

25. Hagberg L., Torres A., van Rensburg D. et al. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia // Infection. — 2002. — Vol. 30 (6). - P. 378-386.

26. Finch R., Schurmann D., Collins O. et al. Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment // Antimicrob. Agents Chemother. — 2002. — Vol. 46 (6). - P. 1746-1754.

Yl.Jardim J. R., Rico G., de la Roza C. et al.\ Grupo de Estudio Latinoa- mericano CAP. A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial // Arch. Bronconeumol. — 2003. — Vol. 39 (9). - P. 387-393.